NDC 38739-600

ZIMHI

Naloxone Hydrochloride

ZIMHI is a Intramuscular; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Adamis Pharmaceuticals. The primary component is Naloxone Hydrochloride.

Product ID38739-600_7dccaf6e-19d0-4720-aac3-c2500a760575
NDC38739-600
Product TypeHuman Prescription Drug
Proprietary NameZIMHI
Generic NameNaloxone Hydrochloride
Dosage FormInjection, Solution
Route of AdministrationINTRAMUSCULAR; SUBCUTANEOUS
Marketing Start Date2022-01-15
Marketing CategoryNDA /
Application NumberNDA212854
Labeler NameAdamis Pharmaceuticals
Substance NameNALOXONE HYDROCHLORIDE
Active Ingredient Strength5 mg/.5mL
Pharm ClassesOpioid Antagonist [EPC], Opioid Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 38739-600-01

1 SYRINGE in 1 CONTAINER (38739-600-01) > .5 mL in 1 SYRINGE
Marketing Start Date2022-01-15
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "ZIMHI" or generic name "Naloxone Hydrochloride"

NDCBrand NameGeneric Name
0093-2165Naloxone HydrochlorideNaloxone Hydrochloride
0404-9920Naloxone HydrochlorideNaloxone Hydrochloride
0404-9921NALOXONE HYDROCHLORIDEnaloxone hydrochloride
0404-9922NALOXONE HYDROCHLORIDEnaloxone hydrochloride
0404-9923NALOXONE HYDROCHLORIDEnaloxone hydrochloride
0409-1215Naloxone HydrochlorideNALOXONE HYDROCHLORIDE
0409-1219Naloxone HydrochlorideNALOXONE HYDROCHLORIDE
0409-1782Naloxone HydrochlorideNALOXONE HYDROCHLORIDE
0641-6205Naloxone HydrochlorideNaloxone Hydrochloride
17478-041Naloxone HydrochlorideNaloxone Hydrochloride

Trademark Results [ZIMHI]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ZIMHI
ZIMHI
88281598 not registered Live/Pending
Adamis Pharmaceuticals Corporation
2019-01-29
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.